Company Filing History:
Years Active: 2022
Title: Damon Papac - Innovator in Vascular Treatment
Introduction
Damon Papac is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of medical treatments, particularly in addressing vascular disorders. His innovative work has led to the development of a patent that holds promise for various medical applications.
Latest Patents
Damon Papac holds a patent for "ARF6 inhibitors and related methods." This patent outlines methods for treating vascular leak, vascular inflammation, angiogenesis, ocular disorders, and inflammatory disorders in patients. The methods involve administering an ADP-ribosylation factor 6 (ARF6) inhibitor, which can include new chemical entities and pharmaceutical compositions. Notably, the ARF6 inhibitor may also be a prodrug of an ARF6 inhibitor, showcasing the potential for advanced therapeutic options.
Career Highlights
Damon Papac is associated with Navigen, Inc., where he continues to work on innovative solutions in the medical field. His expertise and dedication to research have positioned him as a key figure in the development of treatments that address complex vascular issues.
Collaborations
Damon collaborates with talented professionals such as Ashok Bajji and Kirill Ostanin. Their combined efforts contribute to the advancement of research and development in the medical sector.
Conclusion
Damon Papac's work in developing ARF6 inhibitors represents a significant advancement in the treatment of vascular disorders. His contributions to the field highlight the importance of innovation in medical research and the potential for improved patient outcomes.